Mental health issues due to COVID-19 Mental and Behavioural Disorders
Conditions
Interventions
Potential participants will be asked to read the information sheet and complete the consent form and screening questions. Those that reach the threshold score for eligibility on the screening question
Sponsors
Imperial College London
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age 18 or over 2. Score 9 or more on the Covid Anxiety Scale Additionally for the nested feasibility trial 3. Score 20 or more on the Health Anxiety Inventory
Exclusion criteria
Exclusion criteria: 1. A current or previous diagnosis of a psychotic mental disorder Additionally for the nested feasibility trial 2. Has had COVID-19 within the last 4 weeks (defined as a positive antigen test or a diagnosis from a clinician) 3. Has been told, either by a doctor or the NHS Test and Trace service, that they should self-isolate due to the possibility that they have been exposed to covid-19 4. Currently in receipt of a psychological treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COVID Anxiety measured using the Coronavirus Anxiety Scale at screening, 3 and 6 month follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mental Health measured using the Dependent Personality Questionnaire at baseline and 6-month follow up 2. Use of alcohol and drugs measured using the AUDIT-C at baseline and 6-month follow up 3. Anxiety measured using the Generalised Anxiety Disorder 7-item scale at baseline 3-month and 6-month follow up 4. Health Anxiety measured using the Health Anxiety Inventory at baseline 3-month and 6-month follow up 5. Mental Health measured using the Patient Health Questionnaire-9 at baseline 3-month and 6-month follow up 6. Social Function measured using the Work and Social Adjustment Scale at baseline 3-month and 6-month follow up 7. Behaviour measured using the Unvalidated questionnaire on behaviours intended to reduce the risk of exposure to COVID-19 at baseline 3-month and 6-month follow up 8. Mental Health measured using the Obsessive -Compulsive Inventory at baseline 3-month and 6-month follow up 9. Health-related quality of life measured using the EQ-5D at baseline 3-month and 6-month follow up 10. Resource use measured using the Adult Service Use Schedule at baseline 3-month and 6-month follow up 11. Therapy engagement measured using the Number and length of therapy sessions at 6-month follow up at baseline 3-month and 6-month follow up | — |
Countries
England, United Kingdom
Outcome results
None listed